Cargando…
From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work
BACKGROUND: Randomised, double-blind, clinical trial methodology minimises bias in the measurement of treatment efficacy. However, most phase III trials in non-orphan diseases do not include individuals from the population to whom efficacy findings will be applied in the real world. Thus, a translat...
Autores principales: | Boissel, Jean-Pierre, Cogny, Frédéric, Marko, Nicholas, Boissel, François-Henri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702507/ https://www.ncbi.nlm.nih.gov/pubmed/31359347 http://dx.doi.org/10.1007/s40801-019-0159-z |
Ejemplares similares
-
Effect Model Law: An Approach for the Implementation of Personalized Medicine
por: Boissel, Jean-Pierre, et al.
Publicado: (2013) -
Treatment of High Blood Pressure and Gain in Event-Free Life Expectancy
por: Kassaï, Behrouz, et al.
Publicado: (2005) -
High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention
por: Marchant, Ivanny, et al.
Publicado: (2015) -
Revisiting the relationship between baseline risk and risk under treatment
por: Wang, Hao, et al.
Publicado: (2009) -
El naturalismo /
por: Cogny, Pierre
Publicado: (1967)